The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular profiling and targeted agents in recurrent, metastatic salivary gland tumor (R/M SGT) patients (pts) treated at two academic centers.
 
Alberto Hernando-Calvo
Travel, Accommodations, Expenses - Kyowa Kirin International; Merck Serono
 
Alejandra Rezqallah
No Relationships to Disclose
 
Eoghan Ruadh Malone
No Relationships to Disclose
 
Omar Saavedra Santa Gadea
Travel, Accommodations, Expenses - Kyowa Kirin; Merck Sharp & Dohme
 
Anna Spreafico
Honoraria - Bristol-Myers Squibb; Janssen Oncology
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis; Oncorus
Research Funding - Alkermes; Array BioPharma; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Janssen Oncology; Merck; Northern Biologics; Novartis; Replimune; Roche; Surface Oncology; Symphogen
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Idera; Janssen Oncology; Merck; Roche
 
Maria Vieito
Consulting or Advisory Role - Debiopharm Group; Roche; TFS
Travel, Accommodations, Expenses - Merck Serono; Roche
 
Ilan Weinreb
No Relationships to Disclose
 
Susana Aguilar
No Relationships to Disclose
 
Anneli Eliason
No Relationships to Disclose
 
Juan David Assaf
No Relationships to Disclose
 
Angela Rodriguez
No Relationships to Disclose
 
Coro Bescos
No Relationships to Disclose
 
Katherine Lajkosz
No Relationships to Disclose
 
Juan Lorente
No Relationships to Disclose
 
Sarah Jennings
No Relationships to Disclose
 
Enriqueta Felip
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bayer; Blueprint Medicines; Boehringer Ingelheim; Bristol Myers Squibb; Genzyme; GlaxoSmithKline; Janssen; Lilly; Merck Serono; MSD Oncology; Novartis; Pfizer; Puma Biotechnology; Roche; Sanofi; Takeda
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol Myers Squibb; CME outfitters; Lilly; Medscape; Merck Sharp & Dohme; Novartis; PeerVoice; Pfizer; Prime Oncology; Roche; Springer; Takeda; touchIME
Research Funding - EMD Serono (Inst); Merck (Inst)
Other Relationship - GRÍFOLS
 
Elena Garralda
Consulting or Advisory Role - Alkermes; Anaveon; Boehringer Ingelheim; Bristol-Myers Squibb; Ellipses Pharma; Janssen; MAB Discovery; NeoMed; Roche; Seagen; TFS; Thermo Fisher Scientific
Speakers' Bureau - Lilly; MSD; Roche; Thermo Fisher Scientific
Research Funding - AstraZeneca/MedImmune; Novartis; Roche (Inst); Taiho Oncology (Inst); Thermo Fisher Scientific (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Glycotope GmbH; Menarini; Merck Sharp & Dohme
 
Lillian L. Siu
Leadership - Treadwell Therapeutics (I)
Stock and Other Ownership Interests - Agios (I)
Consulting or Advisory Role - Arvinas; AstraZeneca/MedImmune; Daiichi Sankyo/UCB Japan; GlaxoSmithKline; Janpix; Loxo; Merck; Mirati Therapeutics; MorphoSys; Navire; Oncorus; Relay Therapeutics; Roche; Seagen; Symphogen; Treadwell Therapeutics; Voronoi Health Analytics
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AVID Radiopharmaceuticals (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Intensity Therapeutics (Inst); Karyopharm Therapeutics (Inst); MedImmune (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Shattuck Labs (Inst); Symphogen (Inst)
 
Aaron Richard Hansen
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; GlaxoSmithKline; Merck
Research Funding - Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim; Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Macrogenics (Inst); Merck (Inst); Roche/Genentech (Inst)
 
Irene Brana
Consulting or Advisory Role - Achilles Therapeutics; Cancer Expert Now; eTheRNA Immunotherapies; Merck Sharp & Dohme; Rakuten Medical; Sanofi
Speakers' Bureau - Bristol-Myers Squibb; Merck Serono; Roche
Research Funding - AstraZeneca; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Gliknik; Janssen Oncology; Kura Oncology; Merck Sharp & Dohme; Nanobiotix; Novartis; Orion; Pfizer; Roche; Seagen (Inst); Shattuck Labs
Travel, Accommodations, Expenses - AstraZeneca Spain; Merck Serono